1. "Computational Oncology Service"
Formats
  1. Journal Article (576)
  2. Meeting Abstract (374)
  3. Editorial (21)
  4. Review (18)
  5. Research Letter (7)
  6. Conference Paper (6)
  7. Book Section (2)
  8. Guidelines (2)
  9. Miscellaneous (1)
Groups
  1. Computational Oncology Service (1007)
  2. Epidemiology and Biostatistics (1007)
  3. GSK Faculty (953)
  4. Human Oncology and Pathogenesis Program (640)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (575)
  6. Department of Medicine (572)

More Groups

People
  1. Nikolaus Schultz (486)
  2. Elli Papaemmanuil (206)
  3. Michael Berger (177)
  4. David Solit (165)
  5. Francisco Sanchez Vega (137)
  6. Jianjiong Gao (132)

More People

Years
  1. 2025 (41)
  2. 2024 (88)
  3. 2023 (102)
  4. 2022 (144)
  5. 2021 (86)
  6. 2020 (115)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. Blood (95)
  3. Cancer Research (84)
  4. Clinical Cancer Research (52)
  5. Nature Communications (40)
  6. Nature (35)

More Publications

Publishers
  1. American Association for Cancer Research (179)
  2. Nature Publishing Group (145)
  3. American Society of Clinical Oncology (138)
  4. American Society of Hematology (109)
  5. Cell Press (67)
  6. Oxford University Press (54)

More Publishers

Results (1007)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multiple mutations to the same gene are selected for and cooperate to drive cancer
    Meeting Abstract

    Gorelick, A. N.; Reznik, E.; Cai, Y.; Bielski, C.; Bandlamudi, C.; Penson, A.; Jonsson, P.; La, K.; Scaltriti, M.; Schultz, N.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Integrated genomic analysis of Hurthle cell carcinoma reveals TMEM233/PRKAB1 fusion as a novel oncogenic driver
    Meeting Abstract

    Dong, Y.; Ganly, I.; Makarov, V.; Kuo, F.; Deraje, S.; Reznik, E.; Seshan, V.; Nanjangud, G.; Morris, L.; Riaz, N.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Germline SDHA mutations in children and adults with cancer
    Journal Article

    Dubard Gault, M.; Mandelker, D.; Delair, D.; Stewart, C. R.; Kemel, Y.; Sheehan, M. R.; Siegel, B.; Kennedy, J.; Marcell, V.; Arnold, A.; more...
    Cold Spring Harbor Molecular Case Studies (2018)

    Fulltext@MSK | Save
  • The Ivy Glioblastoma Patient Atlas: A novel clinical and radio-genomics resource for early phase clinical trial design and interpretation
    Meeting Abstract

    Ligon, K.; Lupo, J.; Molinaro, A.; Block, S.; Charbonneau, S.; Geduldig, J.; Stemmer-Rachamimov, A.; DeAngelis, L.; Yong, W.; Schultz, N.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Characterization of the genetic landscape of low mutation burden malignancies through multi-parallel genomic and immunologic analysis
    Meeting Abstract

    Trippett, T.; Berger, M.; Narendran, A.; Lyden, D.; Kovalchuk, O.; Bodour, S.; Laquaglia, M.; Ambati, S.; Schultz, N.; Roehrl, M.
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Early detection and molecular characterization of therapy-related leukemia in children reveals patterns of disease transformation and guides future surveillance protocols
    Meeting Abstract

    Spitzer, B.; Gundem, G.; Farnoud, N.; Millard, N.; McGovern, E.; Patel, M.; Levine, M.; Medina, J.; Zhou, Y.; Arango Ossa, J. E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome
    Meeting Abstract

    Labuhn, M.; Perkins, K.; Papaemmanuil, E.; Garnett, C.; Matzk, S.; Amstislavskiy, V.; Metzner, M.; Kennedy, A.; Scheer, C.; Yoshida, K.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Outcomes of relapsed/refractory patients with IDH1/2 mutated AML treated with non-targeted therapy: Results from the NCRI AML trials
    Meeting Abstract

    Hills, R. K.; Gale, R.; Linch, D. C.; Huntly, B. J. P.; Papaemmanuil, E.; Vyas, P.; Burnett, A. K.; Russell, N. H.
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save